Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04052347 · ClinicalTrials.gov registry record · NA
Decision Aid to Assist Low-Risk Nulliparous Women Considering Induction of Labor At 39 Weeks
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04052347: Clinical Trial NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT04052347 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04052347, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The primary objective is to assess if the utilization of a decision-aid increases the likelihood of low-risk nulliparous women undergoing elective induction of labor at 39.0-39.6 weeks
Primary Outcome
Number of subjects who decided to undergo elective induction of labor at 39.0-39.6 weeks after utilization of a decision-aid
Interventions
- BEHAVIORAL Shared decision-making with a Decision-aid
- BEHAVIORAL routine shared decision-making
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-11-25 |
| Est. Completion | 2020-12-01 |
| Phase | NA |
Why NCT04052347 stopped before completion
NCT04052347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Shared decision-making with a Decision-aid is the first listed.
NCT04052347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04052347 about?
NCT04052347 is a clinical study titled "Decision Aid to Assist Low-Risk Nulliparous Women Considering Induction of Labor At 39 Weeks". The primary objective is to assess if the utilization of a decision-aid increases the likelihood of low-risk nulliparous women undergoing elective induction of labor at 39.0-39.6 weeks
What is the current status of trial NCT04052347?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2019-11-25. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT04052347?
The interventions under investigation include: Shared decision-making with a Decision-aid (BEHAVIORAL), routine shared decision-making (BEHAVIORAL).
Who is sponsoring clinical trial NCT04052347?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04052347's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI